Medpace Holdings, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Medpace Holdings, Inc. (MEDP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.93 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-01
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$3.93M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$3.38M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$2.35M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$2.15M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$12.24M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$13.42M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.43M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$3.93M 10-Q · filed 2018-05-01 | -$7.31M derived: sum of 2 quarters · filed 2018-05-01 | -$9.66M derived: sum of 3 quarters · filed 2018-05-01 | -$11.81M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$5.73M derived: sum of 2 quarters · filed 2018-02-27 | -$7.88M derived: sum of 3 quarters · filed 2018-02-27 | -$12.24M 10-K · filed 2018-02-27 |
| 2017-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$4.50M derived: sum of 2 quarters · filed 2017-10-31 | -$8.85M 10-Q · filed 2017-10-31 | -$14.52M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$6.50M 10-Q · filed 2017-08-01 | -$12.17M derived: sum of 3 quarters · filed 2018-05-01 | -$14.27M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-03-31 | -$4.36M 10-Q · filed 2018-05-01 | -$10.02M derived: sum of 2 quarters · filed 2018-05-01 | -$12.13M derived: sum of 3 quarters · filed 2018-05-01 | -$14.36M derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$7.77M derived: sum of 2 quarters · filed 2018-02-27 | -$10.00M derived: sum of 3 quarters · filed 2018-02-27 | -$13.42M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$4.34M derived: sum of 2 quarters · filed 2017-10-31 | -$7.76M 10-Q · filed 2017-10-31 | -$9.53M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$5.65M 10-Q · filed 2017-08-01 | -$7.42M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$3.42M 10-Q · filed 2017-05-02 | -$5.20M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$6.43M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | -$4.66M 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | -$905.99M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |